Paloma Partners Management CO Amgen Inc Transaction History

Paloma Partners Management CO

$3.28 Billion
Q2 2024

A detailed history of Paloma Partners Management CO transactions in Amgen Inc stock. As of the latest transaction made, Paloma Partners Management CO holds 9,676 shares of AMGN stock, worth $3.06 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

9,676

Holding current value

$3.06 Million

% of portfolio

0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $2.54 Million - $3.09 Million	9,676 New	9,676 $3.02 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $1,022 - $1,153	4 New	4 $1,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $2.14 Million - $2.53 Million	9,983 Added 713.07%	11,383 $2.53 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $2.67 Million - $3.26 Million	-11,840 Reduced 89.43%	1,400 $338,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $3.03 Million - $3.85 Million	13,240 New	13,240 $3.48 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $476,416 - $530,168	-2,065 Reduced 33.5%	4,100 $998,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $10.3 Million - $11.4 Million	-46,927 Reduced 88.39%	6,165 $1.49 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $10.6 Million - $12.1 Million	53,092 New	53,092 $11.9 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $2 Million - $2.21 Million	-8,544 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $1.66 Million - $1.93 Million	7,467 Added 693.31%	8,544 $2.13 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $233,041 - $277,510	1,077 New	1,077 $248,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $194,055 - $215,805	-827 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $1.37 Million - $1.68 Million	-6,926 Reduced 89.33%	827 $195,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $1.19 Million - $1.58 Million	6,543 Added 540.74%	7,753 $1.57 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $26 Million - $33.5 Million	-137,586 Reduced 99.13%	1,210 $291,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $6.81 Million - $8.15 Million	39,090 Added 39.21%	138,796 $26.9 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $5.77 Million - $6.76 Million	34,608 Added 53.16%	99,706 $18.4 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $484,550 - $546,194	-2,679 Reduced 3.95%	65,098 $12.4 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $19 Million - $22.2 Million	-106,744 Reduced 61.16%	67,777 $13.2 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $14 Million - $15.8 Million	75,521 Added 76.28%	174,521 $36.2 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $9.83 Million - $11 Million	59,214 Added 148.83%	99,000 $18.3 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $5.65 Million - $6.6 Million	33,346 Added 517.8%	39,786 $6.78 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $2.94 Million - $3.28 Million	-17,395 Reduced 72.98%	6,440 $1.12 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $3.99 Million - $4.55 Million	23,835	23,835 $4.44 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account

Paloma Partners Management CO Amgen Inc Transaction History